Journal of Virology, March 2008, p. 2598-2603, Vol. 82, No. 5
0022-538X/08/$08.00+0 doi:10.1128/JVI.01613-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Institut für Virologie, Universitätsklinikum Essen, Essen, Germany,1 Department of Molecular Virology, Medical Center of Fudan University, Shanghai, People's Republic of China,2 Institut fuer Medizinische Virologie, Justus-Liebig-Universitaet Giessen, Giessen,3 Klinik für Allgemeine Viszeral- und Transplantationschirugie, Univesitaetsklinkum Essen, Essen,4 Institut fuer Pathologie, Universitaetsklinkum Köln, Cologne, Germany5
Received 24 July 2007/ Accepted 14 December 2007
The essential role of multispecific immune responses for the control of hepatitis B virus (HBV) infection implies the need of multimodal therapeutic strategies for chronic HBV infection, including antiviral chemotherapy and immunomodulation. This hypothesis was tested in the woodchuck model by a combination of lamivudine pretreatment and subsequent immunizations of woodchucks chronically infected with woodchuck hepatitis virus. The immunizations were performed with DNA vaccines or antigen-antibody immune complexes (IC)/DNA vaccines. Immunizations with IC/DNA vaccines led to an anti-woodchuck hepatitis virus surface antibody response and significant reductions of viral load and antigenemia, suggesting that such a strategy may be effective against chronic HBV infection.
Published ahead of print on 26 December 2007.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»